<?xml version="1.0" encoding="UTF-8"?><xmi:XMI xmlns:pos="http:///de/tudarmstadt/ukp/dkpro/core/api/lexmorph/type/pos.ecore" xmlns:tcas="http:///uima/tcas.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:cas="http:///uima/cas.ecore" xmlns:tweet="http:///de/tudarmstadt/ukp/dkpro/core/api/lexmorph/type/pos/tweet.ecore" xmlns:morph="http:///de/tudarmstadt/ukp/dkpro/core/api/lexmorph/type/morph.ecore" xmlns:type3="http:///de/tudarmstadt/ukp/dkpro/core/api/frequency/tfidf/type.ecore" xmlns:types="http:///fr/inra/maiage/bibliome/alvisnlp/bibliomefactory/modules/uima/types.ecore" xmlns:dependency="http:///de/tudarmstadt/ukp/dkpro/core/api/syntax/type/dependency.ecore" xmlns:type7="http:///de/tudarmstadt/ukp/dkpro/core/api/semantics/type.ecore" xmlns:type9="http:///de/tudarmstadt/ukp/dkpro/core/api/transform/type.ecore" xmlns:type="http:///de/tudarmstadt/ukp/dkpro/core/api/anomaly/type.ecore" xmlns:type8="http:///de/tudarmstadt/ukp/dkpro/core/api/syntax/type.ecore" xmlns:type4="http:///de/tudarmstadt/ukp/dkpro/core/api/metadata/type.ecore" xmlns:type5="http:///de/tudarmstadt/ukp/dkpro/core/api/ner/type.ecore" xmlns:type6="http:///de/tudarmstadt/ukp/dkpro/core/api/segmentation/type.ecore" xmlns:type2="http:///de/tudarmstadt/ukp/dkpro/core/api/coref/type.ecore" xmlns:constituent="http:///de/tudarmstadt/ukp/dkpro/core/api/syntax/type/constituent.ecore" xmlns:chunk="http:///de/tudarmstadt/ukp/dkpro/core/api/syntax/type/chunk.ecore" xmi:version="2.0">
    <cas:NULL xmi:id="0"/>
    <tcas:DocumentAnnotation xmi:id="8" sofa="1" begin="0" end="1529" language="x-unspecified"/>
    <types:DocumentProxy xmi:id="13" sofa="1" id="BB-cat+ner-23704121" features="18" sections="24"/>
    <cas:Sofa xmi:id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="Is fidaxomicin worth the cost? An economic analysis.&#10;In May 2011, the Food and Drug Administration approved fidaxomicin for the treatment of Clostridium difficile infection (CDI). It has been found to be noninferior to vancomycin; however, its cost-effectiveness for the treatment of CDI remains undetermined.&#10;We developed a decision analytic simulation model to determine the economic value of fidaxomicin for CDI treatment from the third-party payer perspective. We looked at CDI treatment in these 3 cases: (1) no fidaxomicin, (2) only fidaxomicin, and (3) fidaxomicin based on strain typing results.&#10;The incremental cost-effectiveness ratio for fidaxomicin based on screening given current conditions was &gt;$43.7 million per quality-adjusted life-year and using only fidaxomicin was dominated (ie, more costly and less effective) by the other 2 treatment strategies explored. The fidaxomicin strategy tended to remain dominated, even at lower costs. With approximately 50% of CDI due to the NAP1/BI/027 strain, a course of fidaxomicin would need to cost â‰¤$150 to be cost-effective in the treatment of all CDI cases and between $160 and $400 to be cost-effective for those with a non-NAP1/BI/027 strain (ie, treatment based on strain typing).&#10;Given the current cost and NAP1/BI/027 accounting for approximately 50% of isolates, using fidaxomicin as a first-line treatment for CDI is not cost-effective. However, typing and treatment with fidaxomicin based on strain may be more promising depending on the costs of fidaxomicin.&#10;"/>
    <types:FeatureProxy xmi:id="18" key="set" value="train"/>
    <types:SectionProxy xmi:id="24" sofa="1" begin="0" end="1529" name="text" features="" layers="62 72 85 107" relations="120 193 225 253"/>
    <types:LayerProxy xmi:id="62" sofa="1" name="Paragraph" annotations="66"/>
    <cas:FSArray xmi:id="66" elements="34 41 48 55"/>
    <types:AnnotationProxy xmi:id="34" sofa="1" begin="53" end="309" features=""/>
    <types:AnnotationProxy xmi:id="41" sofa="1" begin="310" end="603" features=""/>
    <types:AnnotationProxy xmi:id="48" sofa="1" begin="604" end="1244" features=""/>
    <types:AnnotationProxy xmi:id="55" sofa="1" begin="1245" end="1528" features=""/>
    <types:LayerProxy xmi:id="72" sofa="1" name="Bacteria" annotations="76"/>
    <cas:FSArray xmi:id="76" elements=""/>
    <types:LayerProxy xmi:id="85" sofa="1" name="Title" annotations="89"/>
    <cas:FSArray xmi:id="89" elements="78"/>
    <types:AnnotationProxy xmi:id="78" sofa="1" begin="0" end="52" features=""/>
    <types:LayerProxy xmi:id="107" sofa="1" name="named-entities" annotations="111"/>
    <cas:FSArray xmi:id="111" elements="92"/>
    <types:AnnotationProxy xmi:id="92" sofa="1" begin="141" end="162" features="97 100"/>
    <types:FeatureProxy xmi:id="97" key="ne-type" value="Bacteria"/>
    <types:FeatureProxy xmi:id="100" key="xref" value="1496"/>
    <types:RelationProxy xmi:id="120" sofa="1" features="125" tuples="131 145 159 173" name="Paragraph"/>
    <types:FeatureProxy xmi:id="125" key="kind" value="text"/>
    <types:TupleProxy xmi:id="131" sofa="1" features="135 138" arguments="265"/>
    <types:FeatureProxy xmi:id="135" key="id" value="T4"/>
    <types:FeatureProxy xmi:id="138" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="265" elements="262"/>
    <types:ArgumentProxy xmi:id="262" role="frag0" argument="48"/>
    <types:TupleProxy xmi:id="145" sofa="1" features="149 152" arguments="271"/>
    <types:FeatureProxy xmi:id="149" key="id" value="T5"/>
    <types:FeatureProxy xmi:id="152" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="271" elements="268"/>
    <types:ArgumentProxy xmi:id="268" role="frag0" argument="55"/>
    <types:TupleProxy xmi:id="159" sofa="1" features="163 166" arguments="277"/>
    <types:FeatureProxy xmi:id="163" key="id" value="T2"/>
    <types:FeatureProxy xmi:id="166" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="277" elements="274"/>
    <types:ArgumentProxy xmi:id="274" role="frag0" argument="34"/>
    <types:TupleProxy xmi:id="173" sofa="1" features="177 180" arguments="283"/>
    <types:FeatureProxy xmi:id="177" key="id" value="T3"/>
    <types:FeatureProxy xmi:id="180" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="283" elements="280"/>
    <types:ArgumentProxy xmi:id="280" role="frag0" argument="41"/>
    <types:RelationProxy xmi:id="193" sofa="1" features="198" tuples="204" name="Bacteria"/>
    <types:FeatureProxy xmi:id="198" key="kind" value="text"/>
    <types:TupleProxy xmi:id="204" sofa="1" features="208 211 214" arguments="289"/>
    <types:FeatureProxy xmi:id="208" key="id" value="T6"/>
    <types:FeatureProxy xmi:id="211" key="type" value="Bacteria"/>
    <types:FeatureProxy xmi:id="214" key="NCBI_Taxonomy" value="1496"/>
    <cas:FSArray xmi:id="289" elements="286"/>
    <types:ArgumentProxy xmi:id="286" role="frag0" argument="92"/>
    <types:RelationProxy xmi:id="225" sofa="1" features="230" tuples="236" name="Title"/>
    <types:FeatureProxy xmi:id="230" key="kind" value="text"/>
    <types:TupleProxy xmi:id="236" sofa="1" features="240 243" arguments="295"/>
    <types:FeatureProxy xmi:id="240" key="id" value="T1"/>
    <types:FeatureProxy xmi:id="243" key="type" value="Title"/>
    <cas:FSArray xmi:id="295" elements="292"/>
    <types:ArgumentProxy xmi:id="292" role="frag0" argument="78"/>
    <types:RelationProxy xmi:id="253" sofa="1" features="" tuples="" name="equiv"/>
    <cas:View sofa="1" members="8 13"/>
</xmi:XMI>
